MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0148749
Supra Oncology Private Limited
Supra Oncology Private Limited - healthcare in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.4 Lakh
▼ 88% YoY
Net loss · FY 2025
₹13.42 Lakh
Latest filing
EBITDA · FY 2025
-₹13.42 Lakh
Latest filing
Authorised capital
₹95 Lakh
Registered with MCA
Paid-up capital
₹87.71 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
1
Provident fund records
Directors on board
3
As per MCA filings
About Supra Oncology Private Limited
Data last updated:
Supra Oncology Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the other human health activities segment of the healthcare sector. It was incorporated on 20 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85190TN2019PTC129353.
The company has an authorised share capital of ₹95 Lakh and a paid-up capital of ₹87.71 Lakh. It is led by directors including Ritu Satish Dave and Visweswaran Shangamithra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.4 Lakh, a decline of 88% compared to the previous year. For the same year it recorded a net loss of ₹13.42 Lakh and EBITDA of -₹13.42 Lakh.
The company has about 1 employee on its provident fund (EPFO) records.
Supra Oncology Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0148749). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U85190TN2019PTC129353
Registration Number 129353
Incorporation Date 20 May 2019
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0148749
Key People
Ritu Satish Dave Director Visweswaran Shangamithra Director Balasubramanian Srinivasan Director Recognitions & Rankings of Supra Oncology
Contact details
Supra Oncology Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressNo. 715 – A 7th Floor Spencer Plaza, Suite #1317 Mount Road, Chennai, Tamil Nadu, India – 600002
- IndustryHealthcare, Other Human Health Activities, Human Health Activities
To see the full contact details of Supra Oncology Private Limited, buy the company report.
Comprehensive company report
Supra Oncology Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Supra Oncology is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Supra Oncology Private Limited, buy the company report.
Financials of Supra Oncology Private Limited
FY 2025 filings availableSupra Oncology Private Limited reported revenue of ₹2.4 Lakh (down 88% YoY) for FY 2025.
Revenue · FY 2025
₹2.4 Lakh ▼ 88%
Net loss · FY 2025
₹13.42 Lakh
EBITDA · FY 2025
-₹13.42 Lakh
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 88%
EBITDA CAGR growth
1 year
▲ 44%
3 years · compounded
▲ 15%
5 years · compounded
▼ 52%
Revenue fell 88% in the latest year. EBITDA rose 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹13.42 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.42 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Supra Oncology Private Limited, buy the company report.
Board of directors of Supra Oncology Private Limited
Supra Oncology has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritu Satish Dave | Director | 23 Jun 2022 | 4 Years 4 Months | Current |
| Visweswaran Shangamithra | Director | 30 Jul 2022 | 4 Years 3 Months | Current |
| Balasubramanian Srinivasan | Director | 20 May 2019 | 7 Years 5 Months | Current |
Peer comparison
Supra Oncology Private Limited is compared with the 7 companies closest to it by revenue in the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Supra Oncology Private Limitedthis company | ₹2.4 Lakh (FY 2025) | -₹13.42 Lakh | -88.0% | 1 | Chennai, Tamil Nadu, India | |
| Asian Career World Private Limited | ₹2.4 Lakh (FY 2022) | Vidyaranyapura, Karnataka, India | ||||
| SB Technology Services Private Limited | ₹2.4 Lakh (FY 2023) | 36.0% | Hyderabad, Telangana, India | |||
| Syntrasol Consultants Private Limited | ₹2.4 Lakh (FY 2025) | -11.0% | Thrissur, Kerala, India | |||
| Compkey Consulting Private Limited | ₹2.4 Lakh (FY 2024) | New Delhi, Delhi, India | ||||
| Tackle-D Private Limited | ₹2.4 Lakh (FY 2024) | 48.0% | Kudumangalur, Karnataka, India | |||
| Kloaz Certification Services Private Limited | ₹2.4 Lakh (FY 2024) | -44.0% | Delhi, India | |||
| Kryolan (India) Private Limited | ₹2.4 Lakh (FY 2022) | 0.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Supra Oncology Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Supra Oncology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Supra Oncology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Supra Oncology Private Limited has a workforce of 1 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
Employee count
1
Active EPFO establishments
1
GST
No GST registration is on our record for Supra Oncology Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Supra Oncology Private Limited has 6 board changes on record since 2019: 3 appointments and 3 cessations. The latest: Ritu Satish Dave ceased to be Additional Director on 28 Sep 2022.
AGM
Supra Oncology Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Supra Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Ritu Satish Dave ceased to be Additional Director.
Ceased
Visweswaran Shangamithra ceased to be Additional Director.
Appointed
Visweswaran Shangamithra was appointed as Director.
Ceased
Vijay Balasubramanian ceased to be Director.
Appointed
Ritu Satish Dave was appointed as Director.
Appointed
Balasubramanian Srinivasan was appointed as Director.
Incorporation
20 May 2019
Supra Oncology Private Limited was registered on 20 May 2019 with Roc Chennai & aged 7 years 5 months as per MCA records.
Frequently asked questions
Supra Oncology is an active private limited company based in Chennai, Tamil Nadu, India. The company works in other human health activities, within the healthcare industry. It was incorporated on 20 May 2019 (7+ years old) and is registered under CIN U85190TN2019PTC129353.
Supra Oncology has 3 current directors:
- Ritu Satish Dave - Director
- Visweswaran Shangamithra - Director
- Balasubramanian Srinivasan - Director
The latest financial statements of Supra Oncology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Supra Oncology is U85190TN2019PTC129353. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Supra Oncology was incorporated on 20 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Supra Oncology by revenue are Asian Career World Private Limited, SB Technology Services Private Limited, Syntrasol Consultants Private Limited, Compkey Consulting Private Limited, Tackle-D Private Limited and 2 more, all in the same principal business activity (other professional, scientific and technical activities).
Ritu Satish Dave ceased to be Additional Director on 28 Sep 2022. Visweswaran Shangamithra ceased to be Additional Director on 28 Sep 2022. Visweswaran Shangamithra was appointed as Director on 30 Jul 2022. Supra Oncology has 6 board changes on record in total.
Yes, Supra Oncology is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0148749).
The registered office of Supra Oncology is at No. 715 – A 7th Floor Spencer Plaza, Suite #1317 Mount Road, Chennai, Tamil Nadu, India – 600002.
Supra Oncology operates in the healthcare industry, in the other human health activities segment.
The compliance status of Supra Oncology is compliant as of 29 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages